FDA authorizes use of bivalent mRNA COVID-19 vaccines, monovalent rescinded
SILVER SPRING, MD, April 18, 2023—The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered […]
FDA-approved Pfizer Comirnaty vaccine clarifications
Shortly after the Food and Drug Administration (FDA) granted approval for the Comirnaty COVID-19 vaccine, the Lynnwood Times asked the administration several clarifying questions regarding the approval and the rebranding of Pfizer’s vaccine. Certain components of the FDA’s literature on the matter left questions unanswered. For example, why is the Pfizer-BioNTech COVID-19 Vaccine being marketed […]
Is the Pfizer vaccine FDA approved?
On August 23, the Food and Drug Administration granted approval for a COVID-19 vaccine. But the jab in question is called the “Comirnaty” vaccine. The labels for vials of Pfizer-BioNTech are still marked for “Emergency Use Authorization.” The Food and Drug Administration’s (FDA) approval of a COVID-19 vaccine has encouraged elected officials to move forward […]
FDA Approves First COVID-19 Vaccine
SILVER SPRING, MD, August, 23, 2021 – Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues […]
Vaccine mandate conflicts with FDA approval requirements
OLYMPIA, Wash., August 19, 2021 — Yesterday, Gov. Jay Inslee announced a new vaccine mandate for all public education employees in Washington in light of the Delta variant’s spread. By October 18th, all education personnel must be fully vaccinated. He also reinstated an indoor mask mandate for the general public, which will go into effect […]
